SC
IDXX icon

Schubert & Co’s Idexx Laboratories IDXX Stock Holding History

Schubert & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21
Closed -$10.5K – 733
2023
Q1 		$10.5K Buy
21
+4
+24% +$1.91K 0.01% 212
2022
Q4 		$6.93K Buy
17
+3
+21% +$1.17K 0.01% 314
2022
Q3 		$5K Sell
14
-2
-13% -$735 ﹤0.01% 399
2022
Q2 		$6K Buy
16
+10
+167% +$4.08K 0.01% 294
2022
Q1 		$3K Buy
6
+1
+20% +$526 ﹤0.01% 282
2021
Q4 		$3K Buy
+5
New +$3.14K ﹤0.01% 230

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Schubert & Co's IDXX Position: Q2 2023 in Review

Schubert & Co sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 21 shares — an estimated $10.5K sold.

Schubert & Co first reported a position in IDXX in Q4 2021 and held it in 6 quarters. The position peaked at $10.5K in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Schubert & Co reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 21 Idexx Laboratories shares in Q2 2023, an estimated $10.5K.
  • Schubert & Co first reported a position in Idexx Laboratories in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Idexx Laboratories position peaked at $10.5K in Q1 2023.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.